Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(I-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4-oxadiazoline-2-thiones

被引:364
作者
El-Emam, AA [1 ]
Al-Deeb, OA
Al-Omar, M
Lehmann, J
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
[2] Univ Jena, Inst Pharm, Lehrstuhl Pharmazeut Chem, D-07743 Jena, Germany
关键词
D O I
10.1016/j.bmc.2004.07.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The reaction of 5 -(1-adamantyl)-1, 3,4-oxadiazoline-2-thione 2 with iodoethane, 2-dimethylaminoethyl chloride hydrochloride or 2-piperidinoethyl chloride hydrochloride in ethanolic potassium hydroxide yielded the corresponding 5-(1-adamantyl)-2-ethyl or substituted ethylthio-1,3,4-oxadiazoles 3a-c. Interaction of 2 with formaldehyde solution and primary aromatic amines or 1-substituted piperazines, in ethanol at room temperature yielded the corresponding 5-(1-adamantyl)-3-arylaminomethyl-1,3,4-oxadiazoline-2-thiones 4a-m or 5-(1-adamantyl)-3-(4-substituted-1-piperazinylmethyl)-1,3,4-oxadiazoline-2-thioties 5a-h, respectively. All the synthesized compounds were tested for in vitro activities against certain strains of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus Candida albicans. Compounds 2, 5a, and 5e were found as the most active derivatives, particularly against the Gram-positive bacteria. In addition, the antiviral activity of compounds 2, 4a-m, and 5a-h against HIV-1 using the XTT assay was carried out. Compound 2 produced 100%, 43%, and 37% reduction of viral replication at 50, 10, and 2 mug/mL concentrations, respectively. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5107 / 5113
页数:7
相关论文
共 38 条
[1]
Synthesis and SAR of adatanserin:: Novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents [J].
Abou-Gharbia, MA ;
Childers, WE ;
Fletcher, H ;
McGaughey, G ;
Patel, U ;
Webb, MB ;
Yardley, J ;
Andree, T ;
Boast, C ;
Kucharik, RJ ;
Marquis, K ;
Morris, H ;
Scerni, R ;
Moyer, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) :5077-5094
[2]
THE PETT SERIES, A NEW CLASS OF POTENT NONNUCLEOSIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE [J].
AHGREN, C ;
BACKRO, K ;
BELL, FW ;
CANTRELL, AS ;
CLEMENS, M ;
COLACINO, JM ;
DEETER, JB ;
ENGELHARDT, JA ;
HOGBERG, M ;
JASKUNAS, SR ;
JOHANSSON, NG ;
JORDAN, CL ;
KASHER, JS ;
KINNICK, MD ;
LIND, P ;
LOPEZ, C ;
MORIN, JM ;
MUESING, MA ;
NOREEN, R ;
OBERG, B ;
PAGET, CJ ;
PALKOWITZ, JA ;
PARRISH, CA ;
PRANC, P ;
RIPPY, MK ;
RYDERGARD, C ;
SAHLBERG, C ;
SWANSON, S ;
TERNANSKY, RJ ;
UNGE, T ;
VASILEFF, RT ;
VRANG, L ;
WEST, SJ ;
ZHANG, H ;
XHOU, XX .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1329-1335
[3]
Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2,6-dichloroanilino) phenyl]acetic acid derivatives [J].
Amir, M ;
Shikha, K .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (06) :535-545
[4]
New adamantan-2-ol and adamantan-1-methanol derivatives as potent antibacterials. Synthesis, antibacterial activity and lipophilicity studies [J].
AntoniadouVyza, E ;
Tsitsa, P ;
Hytiroglou, E ;
TsantiliKakoulidou, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (02) :105-110
[5]
Synthesis and antimicrobial activity of some 5-aryl-2-[(N,N-disubstituted thiocarbamoylthio)acylamino]-1,3,4-oxadiazoles [J].
Ates, Ö ;
Kocabalkanli, A ;
Cesur, N ;
Ötük, G .
FARMACO, 1998, 53 (8-9) :541-544
[6]
Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents [J].
Burstein, ME ;
Serbin, AV ;
Khakhulina, TV ;
Alymova, IV ;
Stotskaya, LL ;
Bogdan, OP ;
Manukchina, EE ;
Jdanov, VV ;
Sharova, NK ;
Bukrinskaya, AG .
ANTIVIRAL RESEARCH, 1999, 41 (03) :135-144
[7]
AMANTADINE TREMOR, A 5-HYDROXYTRYPTAMINE-MEDIATED RESPONSE [J].
COX, B ;
THA, SJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 30 (02) :344-351
[8]
A CONTROLLED TRIAL OF AMANTADINE AND RIMANTADINE IN THE PROPHYLAXIS OF INFLUENZA-A INFECTION [J].
DOLIN, R ;
REICHMAN, RC ;
MADORE, HP ;
MAYNARD, R ;
LINTON, PN ;
WEBBERJONES, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (10) :580-584
[9]
EL-EMAM A A, 1990, Chinese Pharmaceutical Journal (Taipei), V42, P309
[10]
El-Emam Ali A., 1993, Chinese Pharmaceutical Journal, V45, P101